Validation of Predictors of Adverse Outcomes in Hospital-Acquired Pneumonia in the ICU*-Reference-Cited by-同舟云学术

Validation of Predictors of Adverse Outcomes in Hospital-Acquired Pneumonia in the ICU*

Published:2013-09 Issue:9 Volume:41 Page:2151-2161
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Esperatti Mariano,Ferrer Miquel,Giunta Valeria,Ranzani Otavio Tavares,Saucedo Lina Maria,Li Bassi Gianluigi,Blasi Francesco,Rello Jordi,Niederman Michael S.,Torres Antoni

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference32 articles.

1. Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients

2. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units

3. Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients

4. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia

5. Challenges in the Design and Conduct of Clinical Trials for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia: An Industry Perspective

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study of non-ventilator hospital-acquired pneumonia in a Norwegian hospital: a serious medical condition in need of better and timelier microbiological diagnostics;Infectious Diseases;2024-06-26

2. Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice;Expert Review of Anti-infective Therapy;2024-05-20

3. Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review;Journal of Clinical Medicine;2023-10-14

4. European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI;Intensive Care Medicine;2023-10

5. Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence;Annals of Intensive Care;2023-06-15